Literature DB >> 6221569

Evidence for a renal origin of urinary thromboxane B2 in health and disease.

C Patrono, G Ciabattoni, P Patrignani, P Filabozzi, E Pinca, M A Satta, D van Dorne, G A Cinotti, F Pugliese, A Pierucci, B M Simonetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6221569

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  10 in total

1.  Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids.

Authors:  Peter Bui; Satoshi Imaizumi; Sudheer Reddy Beedanagari; Srinivasa T Reddy; Oliver Hankinson
Journal:  Drug Metab Dispos       Date:  2010-11-10       Impact factor: 3.922

2.  Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.

Authors:  C Patrono; G Ciabattoni; G Remuzzi; E Gotti; S Bombardieri; O Di Munno; G Tartarelli; G A Cinotti; B M Simonetti; A Pierucci
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

3.  Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension.

Authors:  C Fronzaroli; G La Villa; G Strazzulla; M Mannelli; F Franchi
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.

Authors:  M Hattori; K Ito; H Kawaguchi; T Tanaka; R Kubota; M Khono
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

5.  Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.

Authors:  M L Purkerson; J H Joist; J Yates; A Valdes; A Morrison; S Klahr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Effects of thromboxane synthase inhibitors on renal function.

Authors:  E K Jackson; F Goto; H D Uderman; R J Workman; W A Herzer; G A FitzGerald; R A Branch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

7.  11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.

Authors:  F Catella; D Healy; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Relation of renal thromboxane A2 production to urine flow, electrolyte excretion and plasma renin activity in control state and drug induced hypotension.

Authors:  B Székács; E Mohácsi; B Gachályi; K Tihanyi; I Juhász
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

9.  Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt.

Authors:  I Adatia; S E Barrow; P D Stratton; J M Ritter; S G Haworth
Journal:  Br Heart J       Date:  1994-11

10.  Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.

Authors:  A Aitokallio-Tallberg; L Viinikka; O Ylikorkala
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.